- Featured Product
- KD/KO Validated
BCCIP Polyklonaler Antikörper
BCCIP Polyklonal Antikörper für WB, IF/ICC, IP, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human, Maus, Ratte
Anwendung
WB, IF/ICC, IP, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 16043-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
16043-1-PBS bindet in WB, IF/ICC, IP, Indirect ELISA BCCIP und zeigt Reaktivität mit human, Maus, Ratten
| Getestete Reaktivität | human, Maus, Ratte |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | BCCIP fusion protein Ag8934 |
| Vollständiger Name | BRCA2 and CDKN1A interacting protein |
| Berechnetes Molekulargewicht | 314 aa, 36 kDa |
| Beobachtetes Molekulargewicht | 50-58 kDa |
| GenBank-Zugangsnummer | BC009771 |
| Gene symbol | BCCIP |
| Gene ID (NCBI) | 56647 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
BCCIP (or TOK1) is isolated as a BRCA2- and CDKN1A (p21)-interacting protein and is implicated in homologous recombination (HR) pathway and inhibition of DNA replication stress. BCCIP is an evolutionarily conserved nuclear protein with multiple interacting domains. BCCIP deficiency in mice impaired embryonic and postnatal neural development, causing severe ataxia, cerebral and cerebellar defects, and microcephaly, which are associated with spontaneous DNA damage and subsequent cell death in the proliferative cell populations of the neural system during embryogenesis. BCCIP is essential for maintaining the transactivation activity of wild type p53 suggesting a potential role of BCCIP in cancer etiology.







